Skoči na glavni sadržaj

Pregledni rad

https://doi.org/10.24869/spsih.2023.340

Sarcopenia in Persons Suffering from Dementia

Tonći Mastelić ; Psychiatry Department, University Hospital of Split, Split, Croatia
Vitomir Višić ; Psychiatric Hospital Ugljan, Ugljan, Croatia;
Tonka Borovina Marasović ; Psychiatry Department, University Hospital of Split, Split, Croatia
Marjana Milanović ; Psychiatry Department, University Hospital of Split, Split, Croatia; School of Medicine, University of Split, Split, Croatia
Žana Kralj ; Psychiatry Department, University Hospital of Split, Split, Croatia; School of Medicine, University of Split, Split, Croatia
Eliana Burilović ; Psychiatry Department, University Hospital of Split, Split, Croatia
Milena Pernat ; Psychiatry Department, University Hospital of Split, Split, Croatia
Dora Vukorepa ; Psychiatry Department, University Hospital of Split, Split, Croatia
Nina Rančić ; Psychiatry Department, University Hospital of Split, Split, Croatia
Marija Baković ; Psychiatric Hospital Ugljan, Ugljan, Croatia;
Mladen Mavar ; Psychiatric Hospital Ugljan, Ugljan, Croatia;
Trpimir Glavina ; Psychiatry Department, University Hospital of Split, Split, Croatia; School of Medicine, University of Split, Split, Croatia


Puni tekst: hrvatski pdf 150 Kb

str. 340-353

preuzimanja: 0

citiraj

Puni tekst: engleski pdf 150 Kb

str. 340-353

preuzimanja: 0

citiraj


Sažetak

Sarcopenia is a poorly researched, but increasingly intriguing topic in psychiatry, especially in psychogeriatrics. The aim of
our study was to review the literature on sarcopenia in persons suffering from dementia. The literature was searched using
the PubMed and Google Scholar databases. Dementia and sarcopenia share certain etiological processes and risk factors.
People suffering from dementia have an increased risk of developing sarcopenia. SARC-F is recommended as a screening
tool for sarcopenia, and bioelectrical impedance and dynamometer are recommended for diagnosis. Exercise, proteinrich
diet and protein supplements play a role in prevention and treatment. Additional research is needed with regard to
possible biomarkers of sarcopenia. Additional research should also be conducted regarding the best screening tools, as
well as the diagnostic criteria and means used. Prevention and treatment methods require additional research as well.
Research into all these aspects of sarcopenia should focus more on the population of individuals suffering from dementia.

Ključne riječi

Dementia; Sarcopenia; SARC-F; Guidelines; Protein Supplements

Hrčak ID:

318850

URI

https://hrcak.srce.hr/318850

Datum izdavanja:

17.4.2024.

Podaci na drugim jezicima: hrvatski

Posjeta: 0 *